Middleton K et al. |
Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. |
2017 |
J Biomech |
pmid:28552413
|
Ozaki Y et al. |
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. |
2017 |
PLoS ONE |
pmid:28937990
|
Tschiderer L et al. |
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. |
2017 |
PLoS ONE |
pmid:28837646
|
Åšliwicka E et al. |
Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. |
2017 |
PLoS ONE |
pmid:28732027
|
Bergdolt S et al. |
Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. |
2017 |
PLoS ONE |
pmid:28614388
|
Spirlandeli AL et al. |
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. |
2017 |
Clinics (Sao Paulo) |
pmid:28492723
|
Liu J et al. |
MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. |
2017 |
PLoS ONE |
pmid:28319142
|
Hygum K et al. |
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. |
2017 |
Eur. J. Endocrinol. |
pmid:28049653
|
Dawson S and Lawrie A |
From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. |
2017 |
Pharmacol. Ther. |
pmid:27373854
|
Yu M et al. |
Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. |
2016 Apr-Jun |
J Cancer Res Ther |
pmid:27461682
|